Cite
HARVARD Citation
Goujard, C. et al. (2020). Treating hypoparathyroidism with recombinant human parathyroid hormone (1–34): long-term safety concerns. Lancet. 395 (10232), pp. 1304-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goujard, C. et al. (2020). Treating hypoparathyroidism with recombinant human parathyroid hormone (1–34): long-term safety concerns. Lancet. 395 (10232), pp. 1304-. [Online].